In recent years, ELF3 has been frequently thought as a regulator for cell cycle and epithelial differentiation to participate in the development of several cancers such as oral squamous cell carcinoma, non-small cell lung cancer and prostate cancer [28, -30]. Here, ELF3 is linked to prostate carcinoma.